Latest News for: mmj

Edit

DEA's Diversion Division - Patterns of MMJ's Marijuana Court Case Obstruction, Bias, and Corruption

ACCESSWIRE 03 Apr 2025
DEA Patterns of Obstruction and Corruption MMJ Alleged in Court Hearing ... Duane Boise CEO of MMJ International Holdings, specifically, has pointed to ... MMJ is represented by ... MMJ International Holdings.
Edit

DEA’s Marijuana Legal Blunder and Loss: MMJ Serves Up an April Fools ‘Gift’ a Gut ...

ACCESSWIRE 01 Apr 2025
For the DEA, the joke's on them-and MMJ's legal team is doubling down. As Duane Boise MMJ's CEO quipped ... The saga began in 2018 when MMJ BioPharma Cultivation first applied to grow pharmaceutical marijuana for use in FDA approved clinical trials.
Edit

DEA Forces Marijuana Pharma Drug Industry Offshore: A Symbol of DEA Systemic Obstruction Against Trump ...

ACCESSWIRE 30 Mar 2025
"The mentality," said Duane Boise CEO of MMJ International Holdings ... The MMJ Marijuana Case. ... These delays, MMJ claims, have delayed FDA clinical trials for its flagship drug, MMJ-002, and reflect a broader bias against cannabis-derived medicines.
Edit

DEA Delays Threaten U.S. Leadership in Global Cannabis Pharma Market Despite FDA Advances

ACCESSWIRE 27 Mar 2025
Food and Drug Administrationon MMJ International Holdings' Investigational New Drug (IND) application for MMJ-002, charting a clear course for the advancement of clinical trials ... MMJ is represented by ... MMJ International Holdings.
Edit

DEA Marijuana Policy Reform - Matthew Strait you're Fired - Highlighted in Heated Oversight Congressional Hearing

ACCESSWIRE 24 Mar 2025
, CEO of MMJ International Holdings, and researchers alike ... Earl "Buddy" Carter (R-GA), drawing on his expertise as a pharmacist, since MMJ's application in 2018 ... Duane Boise and MMJ's Protracted Battle ... MMJ is represented by .
Edit

DEA's Marijuana Policy Mission at Odds with Its Actions - MMJ's DEA Lawsuit Positioned to Win

ACCESSWIRE 23 Mar 2025
WASHINGTON, DC / ACCESS Newswire / March 22, 2025 / MMJ International Holdings (MMJ) is advancing cannabis-based therapies through the FDA's clinical trial process, which underscores the scientific validity of its research and highlights the .
  • 1
×